* For illustration purpose only
Active Ingredient: Pioglitazone
Utilization: Used to control high blood sugar in type 2 diabetes (non-insulin-dependent diabetes mellitus)
Available Dosages: 30mg
Last purchase: 18 minutes ago
There are 10 users looking at this product right now
Actos (Pioglitazone) is a hypoglycemic medicine. The effect of Aktos depends on the presence of insulin. It reduces the insulin resistance of the tissues and liver, as a result the absorption of glucose by the tissues increases and its release from the liver decreases. In patients with type II diabetes mellitus, it lowers the blood levels of insulin, sugar levels, as well as glycosylated hemoglobin. Actos is prescribed to people with type II diabetes (alone or in combination with metformin, insulin) as an addition to exercise and diet therapy.
Indication for use
Actos (Pioglitazone) can be taken by almost all adults and teenagers over 18 who have type II diabetes.
Actos (Pioglitazone) is not recommended to use if you have:
· hypersensitivity to pioglitazone or to one of the components of the medicine;
· type 1 diabetes mellitus;
· diabetic ketoacidosis;
· pregnancy, the period of breastfeeding;
· severe heart failure III-IV degree according.
Dose and usage
Dose of Actos (Pioglitazone): 15mg, 30mg, 45mg – white round flat tablets.
Not forget to consult with your attending physician before starting the treatment.
Actos (Pioglitazone) should be taken orally, only once per day. If it is decided to use monotherapy for patients who do not benefit from diet therapy and physical activity, the medicine is prescribed for taking in the amount of 15 or 30 mg of a single dose for one day. The largest dose allowed is 45 mg per day. You can take the drug as part of combination therapy.
Influence of this medicine can trigger some side: weight gain; anemia; decreased visual acuity; hemoglobin decrease; swelling hepatitis; hypoglycemia.
We recommend you to contact your doctor if something disturbs your health.
Medically reviewed by Dr. Josette Davignon
Last updated: 8.04.2021